Global pharmaceutical company Cadila Healthcare net profit declines 

Coursera announces receiving of USD 64 million in Series D funding round

Ahmedabad, Jan 31: Global pharmaceutical company Cadila Healthcare on Tuesday posted a 34.6 per cent decline in its consolidated net profit to Rs 281.6 crore for the quarter ended December 31, 2016 as compared with Rs 430.5 crore in the year-ago period.

The company’s consolidated total income from operations also dipped to Rs 2,363.8 crore during the quarter under review as compared with Rs 2,408.9 crore in a year-ago period.

On BSE, the stock settled at Rs 349.25, down 7.02 per cent from the previous close.

–IANS

Top